BLOW-FILL-SEAL ADVANCED ASEPTIC LIQUID PACKAGING Rommelag® provides Advanced Aseptic liquid packaging solutions with its Blow/Fill/Seal technology. BFS is the standard packaging technology for preservative-free unit-dose ophthalmic drugs. It has the highest Aseptic Assurance Level available. BFS is now available with Preservative Free Multi-Dose (PFMD) formats. mail.romus@rommelag.com or visit us at www.rommelag.com
Ritedose Corp
Ritedose is the largest sterile contract development manufacturing organization (CDMO) in the US specializing in sterile Blow Fill Seal (BFS) technology that ensures sterile, consistent, and safe unit dose delivery. The company’s process guides the development of molecules from clinical trials to commercialization of branded and generic inhalation and ophthalmic medications. With a focus on quality, innovation, and customer satisfaction, Ritedose partners with leading pharmaceutical companies to deliver safe, effective, and reliable medications that improve patient outcomes. For more information about Ritedose and its services: visit Ritedose.com | The Ritedose Corporation is an industry leader in the CDMO, generic and 503B outsourcing markets. Founded in 1995 in Columbia, S.C., we use aseptic cGMP manufacturing and advanced blow-fill-seal (BFS) technology to ensure sterile, efficient and safe unit dose delivery. With its recent land acquisition, Ritedose operates entirely from a 130-acre campus in South Carolina. Ritedose has more than 575 employees and occupies 273,000 square feet of development, manufacturing and packaging space, driving an annual capacity of 2+ billion units. With the newly announced formation of Ritedose Performance Park and the buildout of an additional 225,000 sq ft Central Distribution Center, Ritedose will occupy over a half million sq ft under roof. Our highly touted, 27-year track record since 2012, includes delivery of more than 10 billion doses without a single interruption, and an exceptional inspection history and compliance record as noted by regulators, including the FDA. The Ritedose CDMO team shepherds products from early phase clinicals to commercial scale in an average 18 to 20 days from formulation to shipment and deploys rigorous environmental controls eliminating problems before they occur. The division produces both branded and generic solutions. Ritedose produces suspensions and emulsions for the inhalation, ophthalmic, otic and oral markets. Ritedose Pharmaceuticals provides an uninterrupted, reliable supply chain of unit dose generic inhalation medication for wholesalers and major pharmacy chains across the U.S. Our competitive pricing, aseptic manufacturing platform and packaging innovations allow our partners to feel confident in the products they offer to service patients. Our 503B outsourcing division delivers on-demand, pre-filled critical care syringe products that save valuable time in the pharmacy for clinicians who are stretched thin. Our innovative packaging allows for extended product dating of up to 360 days at room temperature storage. Appropriate product labeling and reliable concentrations facilitate safe patient care reducing potential bedside errors.
ProMed Pharma LLC
ProMed Pharma specializes in hot melt extrusion and injection molding of drug-loaded polymers, applying this expertise to the cGMP manufacture of ophthalmic dosage forms and drug-device combination products. We partner with both early-stage and established pharmaceutical companies, using robust and scalable processes to enable controlled release of active pharmaceutical ingredients (APIs) across a range of polymer systems. From early feasibility through clinical supply and commercial production, ProMed supports the development of controlled-release therapies for intravitreal and intracameral implants, punctal plugs, ocular rings, and related ophthalmic delivery systems. Our facilities are equipped to handle a broad spectrum of potent compounds, including prostaglandins, tyrosine kinase inhibitors (TKIs), antibiotics, and steroids. For more information, please visit www.promedpharmallc.com
Precision Vision
Precision Vision was built on a foundation of excellence, serving clinical trials since the first ETDRS study. Our expertise as the trusted global leader in vision testing tools is the result of decades of dedication and innovation. This commitment to quality extends beyond our products to include dynamic, streamlined certification solutions that deliver higher savings and faster turnarounds for our clients. Brands Include: ETDRS, BCVA, Precision Vision, Pelli-Robson, Mars, Radner, MNRead, IReST, BRVT, Teller, Reichert, Katena, CATS, SpotChecks, Bailey-Lovie, Double-Happy, Blink, Vortex, Barron, Onatec, ASICO, Sharpoint, EagleVision, Sensortek, and more!
Powered Research
Powered Research is a leading preclinical CRO specializing in non-GLP models. Our commitment is to provide cutting-edge solutions in ophthalmology and oncology research, tailored to meet the unique needs of life science R&D companies. Our staff has extensive expertise in the design and development of non-GLP preclinical data packages, including tolerability and pharmacology models, drug distribution studies, and custom experimental designs. We strive to design the right studies for the product to support our clients’ development strategies. Powered Research is well known for rapid study turnaround, and our scientific experts allow for timely study scheduling and execution. A collection of internal protocols for specific models, and we develop custom models based on client specifications and needs.
Oakwood Labs
Oakwood Labs is a specialized contract development and manufacturing organization (CDMO) focused on advanced drug delivery, with particular expertise in long-acting injectable (LAI) technology. The company develops and manufactures biodegradable polymer-based formulations—primarily using PLGA microspheres—that enable sustained, controlled release of small molecules, peptides, and proteins ranging from days up to a year. Leveraging deep scientific know-how and proprietary formulation platforms, Oakwood Labs supports pharmaceutical partners from early-stage development through commercial manufacturing. Its integrated CMO capabilities include formulation development, analytical services, scale-up, aseptic fill-finish, and regulatory support, making it a trusted partner for complex parenteral products that require precision, consistency, and extended-release performance.
MeltPrep
MeltPrep specializes in laboratory equipment for rapid and lossless prototyping of new dosage forms. Our Vacuum Compression Molding (VCM) technology facilitates formulation screening with mg-to-gram-scale sample molding, ensuring homogeneity directly from powders and eliminating air inclusions. Providing solutions for a wide range of applications, including Hot Melt Extrusion (HME), Amorphous Solid Dispersions (ASD), and implant formulation screening, the VCM Platform stands out as a versatile tool for pharmaceutical innovation. In addition to a variety of standard sample sizes, it enables the molding of single prototypes to screen dosage forms with complex geometries using Free-D Molding. Visit our booth to explore our newest innovations: the MeltPrep Slider – quick and easy thermal analysis in minutes, and the MeltPrep Mixer – lossless shear mixing with milligrams.
LTS – Nasal and Sterile Drug Products
At LTS, we CARE for patients, partners, employees, and communities, we CREATE innovative drug delivery solutions, and we DELIVER high-quality products worldwide. As a global CDMO, we provide end-to-end development and manufacturing for pharma and biotech companies. Our technologies include ophthalmics, transdermal patches, oral thin films, nasal and sterile drug delivery products, wearable devices, and microneedle patches. With 40+ commercial products and 50+ active programs, we advance small molecules, biologics, and vaccines. Operating from five sites in the US, Germany, and Israel, plus a China office, LTS combines expertise and patient-centric innovation to power the future of drug delivery.
Lexitas Pharma Services, Inc.
Lexitas is a clinical research organization dedicated exclusively to ophthalmology since 2011. With unmatched expertise and precision in ophthalmic research, we deliver tailored approaches, rigorous quality standards, and unwavering commitment to operational success. Our dedicated team of ophthalmic experts guides each study with deep scientific and clinical experience, offering customized solutions to meet your needs at every stage of development. We have extensive experience in posterior and anterior segments, as well as rare diseases. Service Offerings: -Regulatory strategy -Study design and protocol development -Endpoint evaluation and selection -Site selection, management and training -Clinical project management and monitoring -Medical monitoring -Data management & Biostatistics -Reading center -Medical Affairs & commercialization strategies